{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:08:58Z","timestamp":1791493738569,"version":"4.3.4"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec id=\"ab-ooi250033-4\"><jats:title>Importance<\/jats:title><jats:p>The incidence of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) arising from the palatine tonsil and base of the tongue (BOT) is increasing among the older population. However, data on the prognostic impact of HPV status in patients 70 years and older who undergo up-front surgical treatment remain limited.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi250033-5\"><jats:title>Objective<\/jats:title><jats:p>To evaluate whether HPV status is associated with survival outcomes in patients 70 years or older undergoing surgical treatment for squamous cell carcinoma (SCC) of the tonsil or BOT.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi250033-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This was a retrospective cohort analysis including patients 70 years or older at the time of diagnosis with biopsy specimen\u2212proven and surgically resectable SCC of the tonsil or BOT treated in 10 comprehensive cancer centers from January 1, 2010, to July 31, 2021, with a minimum follow-up period of 3 years. Data analysis was conducted from August 20 to December 23, 2024.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi250033-7\"><jats:title>Exposure<\/jats:title><jats:p>HPV status determined by p16 immunohistochemistry.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi250033-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Overall survival (OS) and disease-free survival (DFS) were compared between p16-positive and p16-negative groups using Cox proportional hazards models.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi250033-9\"><jats:title>Results<\/jats:title><jats:p>The analysis included 345 patients (mean [SD] age, 75.7 [4.8] years; 241 [69.9%] male), of whom 207 (60.0%) underwent a transoral surgical approach and 138 (40.0%), an open surgical technique. Of these, 155 patients (44.9%) had p16-positive and 190 (55.1%) had p16-negative test results. The median (IQR) follow-up duration was 55 (18-87) months. Patients with p16-positive tumors demonstrated significantly improved survival outcomes. Specifically, the 5-year OS rate was 71.4% for patients who had p16-positive vs 47.7% for p16-negative test results, with an absolute difference of 23.7% (95% CI, 13.0%-34.4%) and an adjusted hazard ratio (HR) for OS of 0.36 (95% CI, 0.23-0.57). Similarly, the 5-year DFS rate was 66.4% for patients who were p16-positive compared to 40.8% for those p16-negative, with an absolute difference of 25.6% (95% CI, 14.9%-36.3%) and an adjusted HR for DFS of 0.42 (95% CI, 0.28-0.63)<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi250033-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This cohort study found that p16 positivity was associated with significantly improved survival outcomes, suggesting that HPV-associated tumors maintain their favorable prognosis even in patients 70 years and older who were surgically treated for SCC of the tonsil or BOT.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoto.2025.1722","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T11:31:07Z","timestamp":1751542267000},"page":"795","source":"Crossref","is-referenced-by-count":5,"title":["HPV Status and Survival Outcomes in Patients 70 Years and Older After Surgery for Oropharyngeal Carcinoma"],"prefix":"10.1001","volume":"151","author":[{"given":"Paolo","family":"Boscolo-Rizzo","sequence":"first","affiliation":[{"name":"Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Tagliabue","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Head and Neck Surgery, IEO (European Institute of Oncology), IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Polesel","sequence":"additional","affiliation":[{"name":"Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano, IRCCS, Aviano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Giudici","sequence":"additional","affiliation":[{"name":"Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano, IRCCS, Aviano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Rampinelli","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Spinato","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Section of Otolaryngology, University of Padova, Padova, Italy"},{"name":"Unit of Otolaryngology, Azienda Unit\u00e0 Locale Socio Sanitaria2\u2014Marca Trevigiana, Treviso, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Angelo","family":"Vaira","sequence":"additional","affiliation":[{"name":"Maxillofacial Surgery Operative Unit, Department of Medicine, Surgery, and Pharmacy, University of Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Golusinski","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Maxillofacial Surgery, University of Zielona G\u00f3ra, Zielona G\u00f3ra, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Dequanter","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology and Head and Neck Surgery, Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Chiesa Estomba","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology\u2013Head & Neck Surgery, Hospital Universitario Donostia, San Sebastian, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Maniaci","sequence":"additional","affiliation":[{"name":"Azienda Sanitaria Provinciale Ragusa\u2212Hospital Giovanni Paolo II, Ragusa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Lentini","sequence":"additional","affiliation":[{"name":"Azienda Sanitaria Provinciale Ragusa\u2212Hospital Giovanni Paolo II, Ragusa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"De Berardinis","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Head and Neck Surgery, IEO (European Institute of Oncology), IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Iandolo","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Borsetto","sequence":"additional","affiliation":[{"name":"Department of Ear, Nose, and Throat, Addenbrooke\u2019s Hospital, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Szewczyk","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Poznan University of Medical Sciences, The Greater Poland Cancer Center, Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bussu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Pharmacy, Section of Otolaryngology, University of Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome R.","family":"Lechien","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology and Head and Neck Surgery, Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium"},{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Elsan Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Emanuelli","sequence":"additional","affiliation":[{"name":"Unit of Otolaryngology, Azienda Unit\u00e0 Locale Socio Sanitaria2\u2014Marca Trevigiana, Treviso, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Piazza","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Nicolai","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Section of Otolaryngology, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohssen","family":"Ansarin","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology and Head and Neck Surgery, IEO (European Institute of Oncology), IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Tirelli","sequence":"additional","affiliation":[{"name":"Department of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"14","key":"ooi250033r1","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1002\/cncr.31385","article-title":"Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.","volume":"124","author":"Windon","year":"2018","journal-title":"Cancer"},{"issue":"9","key":"ooi250033r2","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3390\/cancers15092643","article-title":"Rising trend in the prevalence of HPV-driven oropharyngeal squamous cell carcinoma during 2000-2022 in Northeastern Italy: implication for using p16INK4a as a surrogate marker for HPV-driven carcinogenesis.","volume":"15","author":"Boscolo-Rizzo","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"12","key":"ooi250033r3","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jamaoncol.2016.1804","article-title":"Incidence of oropharyngeal cancer among elderly patients in the United States.","volume":"2","author":"Zumsteg","year":"2016","journal-title":"JAMA Oncol"},{"key":"ooi250033r4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejca.2018.08.015","article-title":"Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: dramatically increased prevalence and clinical implications.","volume":"103","author":"Lu","year":"2018","journal-title":"Eur J Cancer"},{"key":"ooi250033r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104687","article-title":"A new face of the HPV epidemic: oropharyngeal cancer in the elderly.","volume":"109","author":"Dickstein","year":"2020","journal-title":"Oral Oncol"},{"issue":"10","key":"ooi250033r6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/jamaoto.2024.2596","article-title":"Safety and postoperative outcomes of transoral surgery for oropharyngeal carcinoma in older adults.","volume":"150","author":"Costantino","year":"2024","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"6","key":"ooi250033r7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.annonc.2022.03.005","article-title":"Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis.","volume":"33","author":"Lang Kuhs","year":"2022","journal-title":"Ann Oncol"},{"issue":"14","key":"ooi250033r8","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1002\/cncr.33505","article-title":"Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: findings from Head and Neck 5000.","volume":"127","author":"Whitmarsh","year":"2021","journal-title":"Cancer"},{"issue":"10166","key":"ooi250033r9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"issue":"10166","key":"ooi250033r10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"ooi250033r11","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hed.24073","article-title":"Clinical outcomes in elderly patients with human papillomavirus-positive squamous cell carcinoma of the oropharynx treated with definitive chemoradiation therapy.","volume":"38","author":"Hanasoge","year":"2016","journal-title":"Head Neck"},{"issue":"1","key":"ooi250033r12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"issue":"4","key":"ooi250033r13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.suronc.2018.08.003","article-title":"Transoral surgery (TOS) in oropharyngeal cancer: different tools, a single mini-invasive philosophy.","volume":"27","author":"Tirelli","year":"2018","journal-title":"Surg Oncol"},{"issue":"4","key":"ooi250033r14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/cncr.33995","article-title":"Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.","volume":"128","author":"Oliver","year":"2022","journal-title":"Cancer"},{"issue":"12","key":"ooi250033r15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1001\/jamaoto.2020.3787","article-title":"Oncologic outcomes following transoral robotic surgery for human papillomavirus-associated oropharyngeal carcinoma in older patients.","volume":"146","author":"Parhar","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ooi250033r16","doi-asserted-by":"publisher","DOI":"10.1002\/hed.28097","article-title":"Transoral surgery versus radiotherapy as primary treatment for HPV-related oropharyngeal cancer in the elderly.","author":"Costantino","year":"2025","journal-title":"Head Neck"},{"issue":"11","key":"ooi250033r17","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1002\/hed.25946","article-title":"Multi-institutional analysis of outcomes following transoral surgery for HPV-positive oropharyngeal squamous cell carcinoma in elderly patients.","volume":"41","author":"Jackson","year":"2019","journal-title":"Head Neck"},{"issue":"6","key":"ooi250033r18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.","volume":"18","author":"Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"issue":"3","key":"ooi250033r19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.6004\/jnccn.2022.0016","article-title":"NCCN Guidelines insights: head and neck cancers, version 1.2022.","volume":"20","author":"Caudell","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"ooi250033r20","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/annonc\/mdq210","article-title":"p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters.","volume":"21","author":"Fischer","year":"2010","journal-title":"Ann Oncol"},{"issue":"6","key":"ooi250033r21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"ooi250033r22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"1","key":"ooi250033r24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer.","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"446","key":"ooi250033r25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"ooi250033r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.104561","article-title":"Comorbidity in head and neck cancer: is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study?","volume":"102","author":"Stordeur","year":"2020","journal-title":"Oral Oncol"},{"issue":"4","key":"ooi250033r27","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.ijrobp.2016.11.044","article-title":"Exploring the impact of human papillomavirus status, comorbidity, polypharmacy, and treatment intensity on outcome of elderly oropharyngeal cancer patients treated with radiation therapy with or without chemotherapy.","volume":"98","author":"Caparrotti","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"ooi250033r28","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/hed.25810","article-title":"Projected oropharyngeal carcinoma incidence among middle-aged US men.","volume":"41","author":"Xu","year":"2019","journal-title":"Head Neck"},{"issue":"1","key":"ooi250033r29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13046-022-02481-4","article-title":"The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-na\u00efve tumors with immune checkpoint inhibitors.","volume":"41","author":"Tosi","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"ooi250033r30","doi-asserted-by":"publisher","first-page":"9320","DOI":"10.1038\/s41598-020-66323-z","article-title":"Age-independent increasing prevalence of human papillomavirus-driven oropharyngeal carcinomas in North-East Italy.","volume":"10","author":"Del Mistro","year":"2020","journal-title":"Sci Rep"},{"key":"ooi250033r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2019.104488","article-title":"HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.","volume":"100","author":"Chatfield-Reed","year":"2020","journal-title":"Oral Oncol"},{"issue":"29","key":"ooi250033r32","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1200\/JCO.2015.61.4115","article-title":"Survivorship and quality of life in head and neck cancer.","volume":"33","author":"Ringash","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"ooi250033r33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311).","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"issue":"15","key":"ooi250033r34","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-CT surveillance versus neck dissection in advanced head and neck cancer.","volume":"374","author":"Mehanna","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"ooi250033r35","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1200\/JCO-24-02755","article-title":"Transoral robotic surgery in the multidisciplinary care of patients with oropharyngeal squamous cell carcinoma: ASCO guideline.","volume":"43","author":"Holsinger","year":"2025","journal-title":"J Clin Oncol"},{"key":"ooi250033r36","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.ejso.2019.09.185","article-title":"Comparative safety and effectiveness of transoral robotic surgery versus open surgery for oropharyngeal cancer: a systematic review and meta-analysis.","volume":"46","author":"Park","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"ooi250033r37","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35287","article-title":"The role of surgery and deescalation for HPV-related oropharyngeal cancer.","volume":"131","author":"Contrera","year":"2025","journal-title":"Cancer"},{"issue":"12","key":"ooi250033r39","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.3390\/cancers12123567","article-title":"Role of human papillomavirus infection in head and neck cancer in Italy: the HPV-AHEAD Study.","volume":"12","author":"Tagliabue","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"ooi250033r40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/annonc\/mdz010","article-title":"Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.","volume":"30","author":"Rasmussen","year":"2019","journal-title":"Ann Oncol"},{"issue":"7","key":"ooi250033r41","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/ijc.30837","article-title":"The AJCC\/UICC eighth edition for staging head and neck cancers: Is it wise to de-escalate treatment regimens in p16-positive oropharyngeal cancer patients?","volume":"141","author":"Boscolo-Rizzo","year":"2017","journal-title":"Int J Cancer"},{"key":"ooi250033r23","volume-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"ooi250033r38","doi-asserted-by":"crossref","unstructured":"Mehanna? H. Treatment De-Escalation of HPV-Positive Oropharyngeal Cancer: Lessons Learnt from Recent Trials. 2023. Accessed May 30, 2025. doi:10.1007\/978-3-031-23175-9_9","DOI":"10.1007\/978-3-031-23175-9_9"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2835837\/jamaotolaryngology_boscolorizzo_2025_oi_250033_1758141828.52533.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T15:19:21Z","timestamp":1758208761000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2835837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2025.1722","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}